152 related articles for article (PubMed ID: 16814622)
1. Raloxifene enhances vertebral mechanical properties independent of bone density.
Allen MR; Iwata K; Sato M; Burr DB
Bone; 2006 Nov; 39(5):1130-1135. PubMed ID: 16814622
[TBL] [Abstract][Full Text] [Related]
2. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
Allen MR; Burr DB
J Bone Miner Res; 2007 Nov; 22(11):1759-65. PubMed ID: 17663638
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
[TBL] [Abstract][Full Text] [Related]
4. Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.
Allen MR; Burr DB
Osteoporos Int; 2008 Jan; 19(1):95-9. PubMed ID: 17710353
[TBL] [Abstract][Full Text] [Related]
5. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
6. Effects of the combination treatment of raloxifene and alendronate on the biomechanical properties of vertebral bone.
Diab T; Wang J; Reinwald S; Guldberg RE; Burr DB
J Bone Miner Res; 2011 Feb; 26(2):270-6. PubMed ID: 20687153
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.
Allen MR; Gineyts E; Leeming DJ; Burr DB; Delmas PD
Osteoporos Int; 2008 Mar; 19(3):329-37. PubMed ID: 18094911
[TBL] [Abstract][Full Text] [Related]
8. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
Meixner CN; Aref MW; Gupta A; McNerny EMB; Brown D; Wallace JM; Allen MR
Calcif Tissue Int; 2017 Jul; 101(1):75-81. PubMed ID: 28246928
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
Berman AG; Wallace JM; Bart ZR; Allen MR
Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
[TBL] [Abstract][Full Text] [Related]
10. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
Tanaka M; Mori H; Kawabata K; Mashiba T
Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
[TBL] [Abstract][Full Text] [Related]
11. Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
Kimura S; Saito M; Kida Y; Seki A; Isaka Y; Marumo K
Osteoporos Int; 2017 Mar; 28(3):1109-1119. PubMed ID: 27796444
[TBL] [Abstract][Full Text] [Related]
12. The effects of strength training and raloxifene on bone health in aging ovariectomized rats.
Stringhetta-Garcia CT; Singulani MP; Santos LF; Louzada MJ; Nakamune AC; Chaves-Neto AH; Rossi AC; Ervolino E; Dornelles RC
Bone; 2016 Apr; 85():45-54. PubMed ID: 26812611
[TBL] [Abstract][Full Text] [Related]
13. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.
Mashiba T; Turner CH; Hirano T; Forwood MR; Johnston CC; Burr DB
Bone; 2001 May; 28(5):524-31. PubMed ID: 11344052
[TBL] [Abstract][Full Text] [Related]
14. Microdamage accumulation in the monkey vertebra does not occur when bone turnover is suppressed by 50% or less with estrogen or raloxifene.
Li J; Sato M; Jerome C; Turner CH; Fan Z; Burr DB
J Bone Miner Metab; 2005; 23 Suppl():48-54. PubMed ID: 15984414
[TBL] [Abstract][Full Text] [Related]
15. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
[TBL] [Abstract][Full Text] [Related]
16. Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene.
Cosman F; Keaveny TM; Kopperdahl D; Wermers RA; Wan X; Krohn KD; Krege JH
J Bone Miner Res; 2013 Jun; 28(6):1328-36. PubMed ID: 23281041
[TBL] [Abstract][Full Text] [Related]
17. Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: a head-to-head comparison with alendronate.
Williams DS; McCracken PJ; Purcell M; Pickarski M; Mathers PD; Savitz AT; Szumiloski J; Jayakar RY; Somayajula S; Krause S; Brown K; Winkelmann CT; Scott BB; Cook L; Motzel SL; Hargreaves R; Evelhoch JL; Cabal A; Dardzinski BJ; Hangartner TN; Duong LT
Bone; 2013 Oct; 56(2):489-96. PubMed ID: 23806798
[TBL] [Abstract][Full Text] [Related]
18. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
[TBL] [Abstract][Full Text] [Related]
19. Effects of suppressed bone remodeling by minodronic acid and alendronate on bone mass, microdamage accumulation, collagen crosslinks and bone mechanical properties in the lumbar vertebra of ovariectomized cynomolgus monkeys.
Mashiba T; Saito M; Yamagami Y; Tanaka M; Iwata K; Yamamoto T
Bone; 2017 Apr; 97():184-191. PubMed ID: 28082077
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]